Management of Hepatocellular Carcinoma: Current Status and Future Directions.
about
Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-AnalysisHepatocellular carcinoma: a reviewChrysin induces cell apoptosis via activation of the p53/Bcl-2/caspase-9 pathway in hepatocellular carcinoma cells.Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study.The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment.Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.New concepts in embolotherapy of HCC.Systemic treatment for hepatocellular carcinoma: Still unmet expectationsSPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers.Sorafenib and a novel immune therapy in lung metastasis from hepatocellular carcinoma following hepatectomy: A case report.Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.Urotensin II receptor as a potential biomarker for the prognosis of hepatocellular carcinoma patients.Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore.Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway.The Evolution of the Use of Serum Alpha-fetoprotein in Clinical Liver Cancer Surveillance
P2860
Q26769591-FD0BC5FA-0D1C-431C-84C9-F8C9FFEC1F61Q28069290-8E47B0B1-5105-4B05-84B3-00B8CBFDCDBAQ37001805-B4CA4A25-83D6-4F4A-A5A3-D6E0E5D81353Q37226397-58F5715C-3F59-42C5-85A1-8EDA9DDFD788Q37336693-328F1EB1-C2C4-430D-8D79-E2B19F5FCEA0Q38803932-5C5FAB9B-740B-4562-8A4B-85340F948A2CQ38904263-EAF74A15-9FF4-4424-8583-46863BE33243Q39112745-AAB6CF58-2CA7-44E0-81E2-C9860722A4CBQ39398940-B2E406AA-D212-4CF7-B5F9-489D1481D087Q39572032-3BAFA0D5-4E01-49F4-A945-A6AB862ABCFCQ40329199-F9EC9DB4-C439-4A2A-A525-03C7918643D0Q41613067-BF4F61E9-39B0-4EEB-AB2C-8420F3521560Q48889483-AACC9D06-027D-443D-8D79-C82A66F1108BQ52584231-DAA90AD4-C90F-4B13-9033-0EC6D1260896Q55515806-1CB8FD82-598A-46D8-B847-4D6B726F40E0Q58457880-0C0D7B8B-9C32-471B-90D8-3B327E205A0F
P2860
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@ast
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@en
type
label
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@ast
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@en
prefLabel
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@ast
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@en
P2860
P356
P1433
P1476
Management of Hepatocellular Carcinoma: Current Status and Future Directions.
@en
P2093
Catherine T Frenette
Jennifer S Au
P2860
P304
P356
10.5009/GNL15022
P5008
P577
2015-07-01T00:00:00Z